Involvement of the hemostatic system in the insulin resistance syndrome: A study of 1500 patients with angina pectoris

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 13, Issue 12, 1993, Pages 1865-1873

  Juhan Vague, I ^a   Thompson, S G ^b   Jespersen, J ^c  

^a TIMONE HOSPITAL   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Centralsygehuset   (Denmark)

Author keywords

Angina pectoris; Arteriosclerosis; Factor VIII; Fibrinogen; Hemostatic system; Insulin; Insulin resistance; Plasminogen activator inhibitor 1; Risk factors; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRINOGEN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; FEMALE; HEART INFARCTION; HEMOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGING; ANGINA PECTORIS; BODY MASS INDEX; CORONARY DISEASE; FACTOR VIII; FEMALE; FIBRINOGEN; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; TRIGLYCERIDES; VON WILLEBRAND FACTOR;

EID: 0027438822     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.13.12.1865     Document Type: Article

References (16)

1. Stout RW. Insulin and atheroma: 20 year perspective. Diabetes Care. 1990;13:631-654.
2. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two populations studies in Finland. Diabetes Care. 1979;2:131-141.
3. Welborn TA, Weame K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
4. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1989;19:205-210.
5. Fontbonne A, Eschwege E. Diabetes, hyperglycaemia, hyperinsulinemia and atherosclerosis: epidemiological data. Diabetes Metab. 1987;13:350-353.
6. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
7. Zimmet P, Baba S. Central obesity, glucose intolerance and other cardiovascular disease risk factors: an old syndrome rediscovered. Diabetes Res Clin Pract. 1990;10:S167-S171.
8. Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D. Plasma plasminogen activator inhibitor in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis. 1989;9:362-367.
9. Rillaerts E, Van Gall L, Xiang DZ, Vansant G, De Leeuw I. Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes. 1989:13:739-745.
10. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 1990;227:273-278.
11. Van Gall L. Body fat distribution: endocrine, metabolic and therapeutic aspects related to atherosclerosis: studies in obesity and type II diabetes: fat distribution and hemorheology. Antwerp, Belgium: Antwerp University; 1990:1-131. Thesis.
12. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism. 1986;35:250-253.
13. Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Allan C. Relationships between plasma insulin, triglyceride, body mass index and plasminogen activator inhibitor 1. Diabetes Metab. 1987:13:331-336.
14. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia. 1991;34:457-462.
15. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
16. Stone MC, Thorpe JM. Plasma fibrinogen-a major coronary risk factor. JR Coll Gen Pract. 1985;35:565-569.